These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 6442475)

  • 21. [Short-course chemotherapy of pulmonary tuberculosis and several problems concerning its use, especially in India].
    Fox W
    Bull Int Union Tuberc; 1985; 60(1-2):44-54. PubMed ID: 3935193
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical and epidemiological aspects of controlled short-term chemotherapy].
    Khomenko AG
    Probl Tuberk; 1998; (4):16-20. PubMed ID: 9771030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Test of short-term monotherapy in the clinical evaluation of the action of antitubercular agents].
    Anastasatu C; Bercea O; Marcian S; Ceicu A
    Arch Monaldi; 1971; 26(4):291-9. PubMed ID: 5004576
    [No Abstract]   [Full Text] [Related]  

  • 24. [Outlook for using a short course of chemotherapy in tuberculosis].
    Anastasatu C; Corlan E
    Probl Tuberk; 1987; (10):31-4. PubMed ID: 3122200
    [No Abstract]   [Full Text] [Related]  

  • 25. Difficulties in the diagnosis and treatment of drug-resistant tuberculosis and tuberculous empyema.
    Glisson J; Mehta JB
    J Tenn Med Assoc; 1992 Sep; 85(9):419-22. PubMed ID: 1405623
    [No Abstract]   [Full Text] [Related]  

  • 26. [An evaluation of the results of the use of a short-duration chemotherapy regimen (3+3) in cases with tuberculosis of the respiratory tract in 1986].
    Didilescu C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1989; 38(2):173-5. PubMed ID: 2555903
    [No Abstract]   [Full Text] [Related]  

  • 27. [Problems in the treatment of patients with pulmonary tuberculosis].
    Chukanov VI
    Probl Tuberk; 1997; (4):17-9. PubMed ID: 9333807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Possibilities and value in the drug therapy of tuberculosis].
    Sighart H
    Wien Med Wochenschr; 1977 Jun; 127(13):418-21. PubMed ID: 408982
    [No Abstract]   [Full Text] [Related]  

  • 29. [Evaluation of early results of treatment of pulmonary tuberculosis in Mycobacterium-positive patients. Comparison of the results of 3- and 4-drug treatment].
    Martyniak K; Wyczółkowski M; Bochiński T
    Pneumonol Pol; 1985 Apr; 53(4):195-201. PubMed ID: 3931056
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical significance of Mycobacterium tuberculosis polydrug resistance in chronic destructive forms of pulmonary tuberculosis].
    Bialik IB; Klimenko MT
    Probl Tuberk; 1980 Oct; (10):68-70. PubMed ID: 6776517
    [No Abstract]   [Full Text] [Related]  

  • 31. [Short-term treatment of tuberculosis with and without pyrazinamide in the second phase (TA-80)].
    Farga V; Valenzuela P; Yañez A; Valenzuela MT; Scheel G; Mendoza F; Torres E; Icekson I; Grinspun M; Fernández M
    Rev Med Chil; 1983 Jul; 111(7):750-4. PubMed ID: 6680460
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pathogenetic drugs in the treatment of destructive pulmonary tuberculosis in adolescents and adults].
    Buĭko RG; Maksimova NM
    Probl Tuberk; 1984 Jan; (1):45-9. PubMed ID: 6422459
    [No Abstract]   [Full Text] [Related]  

  • 33. [Formation of a filterable form of the causative agent of tuberculosis in the chemotherapy process (an experimental study)].
    Khomenko AK; Golyshevskaia VI; Korolev MB; Drozdov SG
    Probl Tuberk; 1982 Mar; (3):50-4. PubMed ID: 6806805
    [No Abstract]   [Full Text] [Related]  

  • 34. [Late results of 12-month-long hospital treatment of chronic pulmonary tuberculosis with rifampicin combined with other antitubercular agents].
    Danilczuk R; Piekarniak K; Wyczólkowski M; Martyniak K
    Pneumonol Pol; 1977 Feb; 45(2):125-30. PubMed ID: 840724
    [No Abstract]   [Full Text] [Related]  

  • 35. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Impact of drug resistance on the fitness of Mycobacteruim tuberculosis of the genotype W-Beijing].
    Tungusova OS; Mar'iandyshev AO; Kaugant DA; Sandven P; Bjeune G
    Probl Tuberk Bolezn Legk; 2005; (8):46-50. PubMed ID: 16209021
    [No Abstract]   [Full Text] [Related]  

  • 37. [Importance of microbiological research in correcting the antibacterial therapy of tuberculosis].
    Dolzhanskiĭ VM; Sagalovich VIa
    Ter Arkh; 1987; 59(7):77-80. PubMed ID: 3118492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficacy of chemotherapy of pulmonary tuberculosis drug-resistant m.tuberculosis].
    Khomenko AG; Chukanov VI; Korneev AA
    Probl Tuberk; 1996; (6):42-4. PubMed ID: 9019768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Improved methods of isolating altered forms of Mycobacterium tuberculosis in patients with stable destructive changes in lung tissue].
    Golyshevskaia VI; Akhunov ShB; Bibergal' EA
    Probl Tuberk; 1987; (10):61-5. PubMed ID: 3122201
    [No Abstract]   [Full Text] [Related]  

  • 40. [The relation between bacilli negative conversion rate and the number of combined sensitive antituberculous drugs in intermittent administration of rifampicin for severe pulmonary tuberculosis].
    Tamura M; Yamazaki A; Tamura T; Takano S; Yamazaki M
    Kekkaku; 1973 Jul; 48(7):297-302. PubMed ID: 4200058
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.